> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Germitec’s Chronos Gets De Novo Marketing Pass
- URL: https://www.fdaweb.com/germitecs-chronos-gets-de-novo-marketing-pass/
- Published: 2024-09-30T12:00:00.000Z
- Updated: 2026-09-14T14:42:43.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157885

FDA has granted a de novo marketing clearance for Germitec’s Chronos automated disinfection device for reducing the risk of cross-contamination. The one-button, chemical-free automated device uses UV-C technology to “penetrate the membrane of microorganisms, disrupting their DNA, RNA, and cellular proteins, thereby halting their replication and capacity to infect, hence dramatically reducing cross-contamination,” the company says. It says the device is indicated for use in a healthcare environment to achieve, in about 90 seconds, high-level disinfection of external, transvaginal, and transrectal ultrasound probes that do not contain lumens and indentations or channels that are deeper than their widths.